Cargando…
Immune-related dissociated response as a specific atypical response pattern in solid tumors with immune checkpoint blockade
Immune checkpoint blockade using immune checkpoint inhibitors, including cytotoxic T-lymphocyte-associated antigen–4 and programmed cell death protein-1/programmed cell death ligand–1 inhibitors, has revolutionized systematic treatment for advanced solid tumors, with unprecedented survival benefit a...
Autores principales: | Guan, Yaping, Feng, Dongfeng, Yin, Beibei, Li, Kun, Wang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083034/ https://www.ncbi.nlm.nih.gov/pubmed/35547094 http://dx.doi.org/10.1177/17588359221096877 |
Ejemplares similares
-
Impact of endogenous glucocorticoid on response to immune checkpoint blockade in patients with advanced cancer
por: Cui, Yu, et al.
Publicado: (2023) -
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
por: Miao, Diana, et al.
Publicado: (2018) -
Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017) -
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
por: Petitprez, Florent, et al.
Publicado: (2020) -
Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
por: Gu, Shengqing Stan, et al.
Publicado: (2020)